The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 23, 2024

Filed:

Oct. 05, 2022
Applicants:

Fresenius Medical Care Holdings, Inc., Waltham, MA (US);

Fresenius Medical Care Deutschland Gmbh, Bad Homburg, DE;

Inventors:

Peter Kotanko, New York, NY (US);

Ulrike Kotanko, Waltham, MA (US);

Sabrina Casper, Bad Homburg, DE;

David Joerg, Bad Homburg, DE;

Gudrun Schappacher-Tilp, Waltham, MA (US);

Doris Fuertinger, Long Island City, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16H 50/50 (2018.01); G16H 50/30 (2018.01);
U.S. Cl.
CPC ...
G16H 50/50 (2018.01); G16H 50/30 (2018.01);
Abstract

A computing system for determining a systematic training strategy for the user is provided. The computing system includes a user device that uses one or more sensors to obtain partial pressure of oxygen (PO2) levels of a user over a period of time. The user device provides previous PO2 levels to a personalized erythropoiesis model generation computing platform. The computing platform obtains individualized user data for the user indicating or more previous hematocrit and/or hemoglobin measurements for the user. The computing platform determines an individualized erythropoiesis model for the user based on the one or more previous hematocrit and/or hemoglobin measurements and the previous PO2 information, and employs the individualized erythropoiesis model to determine predicted hematocrit and/or hemoglobin measurements. The computing platform performs one or more actions based on the one or more predicted hematocrit and/or hemoglobin measurements.


Find Patent Forward Citations

Loading…